May 17 (Reuters) - Vascular Biogenics Ltd:
* VBL THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.24
* SAYS CASH, CASH EQUIVALENTS AND SHORT-TERM BANK DEPOSITS AT MARCH 31, 2018, WERE $49.9 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
Our Standards: The Thomson Reuters Trust Principles.